{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:28:54Z","timestamp":1791268134182,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science foundation of China","doi-asserted-by":"crossref","award":["81270630"],"award-info":[{"award-number":["81270630"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science foundation of China","doi-asserted-by":"crossref","award":["81172592"],"award-info":[{"award-number":["81172592"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Science and Technology Special Project in Clinical Medicine of Jiangsu Province","award":["BL2012056"],"award-info":[{"award-number":["BL2012056"]}]},{"name":"333 Project of Jiangsu Province","award":["BRA2013136"],"award-info":[{"award-number":["BRA2013136"]}]},{"name":"Science and Technology Infrastructure Program of Zhenjiang","award":["SS2012003"],"award-info":[{"award-number":["SS2012003"]}]},{"name":"Social Development Foundation of Zhenjiang","award":["SH2013042"],"award-info":[{"award-number":["SH2013042"]}]},{"name":"Social Development Foundation of Zhenjiang","award":["SH2013082"],"award-info":[{"award-number":["SH2013082"]}]},{"name":"Social Development Foundation of Zhenjiang","award":["SH2014044"],"award-info":[{"award-number":["SH2014044"]}]},{"name":"Social Development Foundation of Zhenjiang","award":["SH2014086"],"award-info":[{"award-number":["SH2014086"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.bbrc.2015.06.095","type":"journal-article","created":{"date-parts":[[2015,6,15]],"date-time":"2015-06-15T17:23:25Z","timestamp":1434389005000},"page":"1250-1256","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Epigenetic inactivation of DLX4 is associated with disease progression in chronic myeloid leukemia"],"prefix":"10.1016","volume":"463","author":[{"given":"Jing-Dong","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Juan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-qin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Ming","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Chun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Mei","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2015.06.095_bib1","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0140-6736(07)61165-9","article-title":"Chronic myeloid leukaemia","volume":"370","author":"Hehlmann","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.bbrc.2015.06.095_bib2","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nrc1567","article-title":"Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukemia","volume":"5","author":"Ren","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbrc.2015.06.095_bib3","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nrc2368","article-title":"Getting to the stem of chronic myeloid leukaemia","volume":"8","author":"Savona","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbrc.2015.06.095_bib4","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/243290a0","article-title":"Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining","volume":"243","author":"Rowley","year":"1973","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2015.06.095_bib5","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.1182\/blood-2003-12-4111","article-title":"The biology of CML blast crisis","volume":"103","author":"Calabretta","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2015.06.095_bib6","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.3324\/haematol.2013.092007","article-title":"Epigenetics in the hematologic malignancies","volume":"99","author":"Fong","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.bbrc.2015.06.095_bib7","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/978-1-61779-612-8_7","article-title":"Epigenetics in myeloid malignancies","volume":"863","author":"Deneberg","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bbrc.2015.06.095_bib8","doi-asserted-by":"crossref","first-page":"e22110","DOI":"10.1371\/journal.pone.0022110","article-title":"Aberrant DNA methylation is associated with disease progression, resistance to imatinib and shortened survival in chronic myelogenous leukemia","volume":"6","author":"Jelinek","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2015.06.095_bib9","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/nrc907","article-title":"Deregulated homeobox gene expression in cancer: cause or consequence?","volume":"2","author":"Abate-Shen","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbrc.2015.06.095_bib10","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/ajmg.a.31252","article-title":"Dlx homeobox gene control of mammalian limb and craniofacial development","volume":"140","author":"Kraus","year":"2006","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.bbrc.2015.06.095_bib11","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.7150\/ijbs.4458","article-title":"DLX4 upregulates TWIST and enhances tumor migration, invasion and metastasis","volume":"8","author":"Zhang","year":"2012","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bbrc.2015.06.095_bib12","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.placenta.2005.03.007","article-title":"Inhibition of DLX4 promotes apoptosis in choriocarcinoma cell lines","volume":"27","author":"Sun","year":"2006","journal-title":"Placenta"},{"key":"10.1016\/j.bbrc.2015.06.095_bib13","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1038\/sj.leu.2401912","article-title":"BP1, a new homeobox gene, is frequently expressed in acute leukemias","volume":"14","author":"Haga","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.bbrc.2015.06.095_bib14","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.clinbiochem.2008.03.011","article-title":"Prognostic significance of BP1 mRNA expression level in patients with non-small cell lung cancer","volume":"41","author":"Yu","year":"2008","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.bbrc.2015.06.095_bib15","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1349-7006.2007.00661.x","article-title":"Expression level of beta protein 1 mRNA in Chinese breast cancer patients: A potential molecular marker for poor prognosis","volume":"99","author":"Yu","year":"2008","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbrc.2015.06.095_bib16","doi-asserted-by":"crossref","first-page":"318","DOI":"10.4149\/neo_2014_041","article-title":"DLX4 as a prognostic marker for hepatocellular carcinoma","volume":"61","author":"Gao","year":"2014","journal-title":"Neoplasma"},{"key":"10.1016\/j.bbrc.2015.06.095_bib17","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/ijc.21054","article-title":"Identification of 20 genes aberrantly methylated in human breast cancers","volume":"116","author":"Miyamoto","year":"2005","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbrc.2015.06.095_bib18","doi-asserted-by":"crossref","first-page":"499","DOI":"10.4161\/epi.5.6.12179","article-title":"Genome-wide DNA methylation profiling of chronic lymphocytic leukemia allows identification of epigenetically repressed molecular pathways with clinical impact","volume":"5","author":"Tong","year":"2010","journal-title":"Epigenetics"},{"key":"10.1016\/j.bbrc.2015.06.095_bib19","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s13277-011-0282-2","article-title":"DNA methylation biomarkers for lung cancer","volume":"33","author":"Rauch","year":"2012","journal-title":"Tumor. Biol."},{"key":"10.1016\/j.bbrc.2015.06.095_bib20","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/dc.23256","article-title":"Aberrant DNA methylation of DLX4 and SIM1 is a predictive marker for disease progression of uterine cervical low-grade squamous intraepithelial lesion","volume":"43","author":"Sakane","year":"2015","journal-title":"Diagn. Cytopathol."},{"key":"10.1016\/j.bbrc.2015.06.095_bib21","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1016\/j.athoracsur.2014.12.058","article-title":"Methylated DLX4 Predicts Response to Pathologic Stage I Non-Small Cell Lung Cancer Resection","volume":"99","author":"Harada","year":"2015","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.bbrc.2015.06.095_bib22","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","year":"2008"},{"key":"10.1016\/j.bbrc.2015.06.095_bib23","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1182\/blood-2009-11-254441","volume":"116","author":"Grimwade","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2015.06.095_bib24","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1600-0609.2008.01178.x","article-title":"Aberrant methylation of the death-associated protein kinase 1 (DAPK1) CpG island in chronic myeloid leukemia","volume":"82","author":"Qian","year":"2009","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.bbrc.2015.06.095_bib25","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s12032-014-0386-9","article-title":"Overexpression of BAALC: clinical significance in Chinese de novo acute myeloid leukemia","volume":"32","author":"Zhou","year":"2015","journal-title":"Med. Oncol."},{"key":"10.1016\/j.bbrc.2015.06.095_bib26","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.3892\/or.2014.3098","article-title":"Methylation and decreased expression of SHP-1 are related to disease progression in chronic myelogenous leukemia","volume":"31","author":"Li","year":"2014","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbrc.2015.06.095_bib27","doi-asserted-by":"crossref","first-page":"7213","DOI":"10.1038\/sj.onc.1208866","article-title":"Promoter hypomethylation of the LINE-1 retrotransposable elements activates sense\/antisense transcription and marks the progression of chronic myeloid leukemia","volume":"24","author":"Roman-Gomez","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2015.06.095_bib28","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3892\/ol.2011.419","article-title":"Aberrant methylation in promoter-associated CpG islands of multiple genes in chronic myelogenous leukemia blast crisis","volume":"3","author":"Uehara","year":"2012","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbrc.2015.06.095_bib29","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.leukres.2007.02.016","article-title":"Epigenetic regulation of PRAME gene in chronic myeloid leukemia","volume":"31","author":"Roman-Gomez","year":"2007","journal-title":"Leuk. Res."},{"key":"10.1016\/j.bbrc.2015.06.095_bib30","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1179\/1607845413Y.0000000081","article-title":"Methylation status of CEBPA gene promoter in chronic myeloid leukemia","volume":"19","author":"Annamaneni","year":"2014","journal-title":"Hematology"},{"key":"10.1016\/j.bbrc.2015.06.095_bib31","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.3892\/mmr.2015.3554","article-title":"Regulation of the oncogenic function of distal-less 4 by microRNA-122 in hepatocellular carcinoma","volume":"12","author":"Xie","year":"2015","journal-title":"Mol. Med. Rep."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X15301455?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X15301455?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T14:29:53Z","timestamp":1717943393000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X15301455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0006291X15301455"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2015.06.095","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epigenetic inactivation of DLX4 is associated with disease progression in chronic myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2015.06.095","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}